1. A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicity. Issue 2 (4th November 2019) Authors: Lewitus, Eric; Rolland, Morgane Journal: Virus evolution Issue: Volume 5:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey. Issue 11 (November 2020) Authors: Hemelaar, Joris; Elangovan, Ramyiadarsini; Yun, Jason; Dickson-Tetteh, Leslie; Kirtley, Shona; Gouws-Williams, Eleanor; Ghys, Peter D; Abimiku, Alash'le G; Agwale, Simon; Archibald, Chris; Avidor, Boaz; Barbás, María Gabriela; Barre-Sinoussi, Francoise; Barugahare, Banson; Belabbes, El Hadj; Bert... Journal: Lancet Issue: Volume 7:Issue 11(2020) Page Start: e772 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine. Issue 4 (25th January 2018) Authors: Herbeck, Joshua T.; Peebles, Kathryn; Edlefsen, Paul T.; Rolland, Morgane; Murphy, James T.; Gottlieb, Geoffrey S.; Abernethy, Neil; Mullins, James I.; Mittler, John E.; Goodreau, Steven M. Journal: Vaccine Issue: Volume 36:Issue 4(2018) Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria. (1st January 2022) Authors: Oluniyi, Paul E.; Ajogbasile, Fehintola V.; Zhou, Shuntai; Fred-Akintunwa, Iyanuoluwa; Polyak, Christina S.; Ake, Julie A.; Tovanabutra, Sodsai; Iroezindu, Michael; Rolland, Morgane; Happi, Christian T. Journal: AIDS Issue: Volume 36:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria. (1st January 2022) Authors: Oluniyi, Paul E.; Ajogbasile, Fehintola V.; Zhou, Shuntai; Fred-Akintunwa, Iyanuoluwa; Polyak, Christina S.; Ake, Julie A.; Tovanabutra, Sodsai; Iroezindu, Michael; Rolland, Morgane; Happi, Christian T. Journal: AIDS Issue: Volume 36:Number 1(2022) Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Multiple co-circulating HIV-1 subtypes in the Middle East and North Africa. (17th July 2015) Authors: Rolland, Morgane; Modjarrad, Kayvon Journal: AIDS Issue: Volume 29:Number 11(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection. Issue 2 (9th July 2021) Authors: Lewitus, Eric; Sanders-Buell, Eric; Bose, Meera; O'Sullivan, Anne Marie; Poltavee, Kultida; Li, Yifan; Bai, Hongjun; Mdluli, Thembi; Donofrio, Gina; Slike, Bonnie; Zhao, Hong; Wong, Kim; Chen, Lennie; Miller, Shana; Lee, Jenica; Ahani, Bahar; Lepore, Steven; Muhammad, Sevan; Grande, Rebecca; Tran... Journal: Virus evolution Issue: Volume 7:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial. Issue 5 (May 2019) Authors: Crowell, Trevor A; Colby, Donn J; Pinyakorn, Suteeraporn; Sacdalan, Carlo; Pagliuzza, Amélie; Intasan, Jintana; Benjapornpong, Khunthalee; Tangnaree, Kamonkan; Chomchey, Nitiya; Kroon, Eugène; de Souza, Mark S; Tovanabutra, Sodsai; Rolland, Morgane; Eller, Michael A; Paquin-Proulx, Dominic; Bolto... Journal: Lancet Issue: Volume 6:Issue 5(2019) Page Start: e297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial. Issue 5 (May 2019) Authors: Crowell, Trevor A; Colby, Donn J; Pinyakorn, Suteeraporn; Sacdalan, Carlo; Pagliuzza, Amélie; Intasan, Jintana; Benjapornpong, Khunthalee; Tangnaree, Kamonkan; Chomchey, Nitiya; Kroon, Eugène; de Souza, Mark S; Tovanabutra, Sodsai; Rolland, Morgane; Eller, Michael A; Paquin-Proulx, Dominic; Bolto... Journal: Lancet Issue: Volume 6:Issue 5(2019) Page Start: e297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. T Cell Immunity and Zika Virus Vaccine Development. Issue 8 (August 2017) Authors: Lima, Noemia S.; Rolland, Morgane; Modjarrad, Kayvon; Trautmann, Lydie Journal: Trends in immunology Issue: Volume 38:Issue 8(2017) Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗